These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 30843890)

  • 1. Management of adults with Burkitt lymphoma.
    Gastwirt JP; Roschewski M
    Clin Adv Hematol Oncol; 2018 Dec; 16(12):812-822. PubMed ID: 30843890
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intensive chemotherapy with cyclophosphamide, doxorubicin, high-dose methotrexate/ifosfamide, etoposide, and high-dose cytarabine (CODOX-M/IVAC) for human immunodeficiency virus-associated Burkitt lymphoma.
    Wang ES; Straus DJ; Teruya-Feldstein J; Qin J; Portlock C; Moskowitz C; Goy A; Hedrick E; Zelenetz AD; Noy A
    Cancer; 2003 Sep; 98(6):1196-205. PubMed ID: 12973843
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Burkitt leukaemia/lymphoma: R-CODOX-M/R-IVAC remains gold standard treatment in BL.
    Smyth L; Browne PV; Conneally E; Flynn C; Hayden P; Jeffers M; O'Brien D; Quinn F; Kelly J; Perera M; Crotty GM; Leahy M; Hennessy B; Jackson F; Ryan M; Vandenberghe E
    Ir J Med Sci; 2016 Nov; 185(4):773-777. PubMed ID: 25843016
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Outcomes of Burkitt lymphoma with central nervous system involvement: evidence from a large multicenter cohort study.
    Zayac AS; Evens AM; Danilov A; Smith SD; Jagadeesh D; Leslie LA; Wei C; Kim SH; Naik S; Sundaram S; Reddy N; Farooq U; Kenkre VP; Epperla N; Blum KA; Khan N; Singh D; Alderuccio JP; Godara A; Yazdy MS; Diefenbach C; Rabinovich E; Varma G; Karmali R; Shao Y; Trabolsi A; Burkart M; Martin P; Stettner S; Chauhan A; Choi YK; Straker-Edwards A; Klein A; Churnetski MC; Boughan KM; Berg S; Haverkos BM; Orellana-Noia VM; D'Angelo C; Bond DA; Maliske SM; Vaca R; Magarelli G; Sperling A; Gordon MJ; David KA; Savani M; Caimi P; Kamdar M; Lunning MA; Palmisiano N; Venugopal P; Portell CA; Bachanova V; Phillips T; Lossos IS; Olszewski AJ
    Haematologica; 2021 Jul; 106(7):1932-1942. PubMed ID: 33538152
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Burkitt lymphoma, a diagnostic emergency].
    Bredin S; Vergé V; Ribrag V
    Rev Prat; 2016 Jan; 66(1):79-82. PubMed ID: 30512408
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Burkitt lymphoma - no impact of HIV status on outcomes with rituximab-based chemoimmunotherapy.
    Tan JY; Qiu TY; Chiang J; Tan YH; Yang VS; Chang EWY; Poon E; Somasundaram N; Farid M; Tao M; Lim ST; Chan JY
    Leuk Lymphoma; 2023 Mar; 64(3):586-596. PubMed ID: 35188049
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treating Burkitt Lymphoma in Adults.
    Casulo C; Friedberg J
    Curr Hematol Malig Rep; 2015 Sep; 10(3):266-71. PubMed ID: 26013028
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Burkitt's and Burkitt-like lymphoma.
    Evens AM; Gordon LI
    Curr Treat Options Oncol; 2002 Aug; 3(4):291-305. PubMed ID: 12074766
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment of relapsed aggressive lymphomas: regimens with and without high-dose therapy and stem cell rescue.
    Hagemeister FB
    Cancer Chemother Pharmacol; 2002 May; 49 Suppl 1():S13-20. PubMed ID: 12042984
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A 5-drug regimen maximizing the dose of cyclophosphamide is effective therapy for adult Burkitt or Burkitt-like lymphomas.
    Kujawski LA; Longo WL; Williams EC; Turman NJ; Brandt N; Mosher DF; Eickhoff JC; Kahl BS
    Cancer Invest; 2007 Mar; 25(2):87-93. PubMed ID: 17453819
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Aggressive B cell Lymphoma: Optimal Therapy for MYC-positive, Double-Hit, and Triple-Hit DLBCL.
    Dunleavy K
    Curr Treat Options Oncol; 2015 Dec; 16(12):58. PubMed ID: 26634708
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adult Burkitt lymphoma: advances in diagnosis and treatment.
    Aldoss IT; Weisenburger DD; Fu K; Chan WC; Vose JM; Bierman PJ; Bociek RG; Armitage JO
    Oncology (Williston Park); 2008 Nov; 22(13):1508-17. PubMed ID: 19133605
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Acute left ventricular insufficiency in a Burkitt Lymphoma patient with myocardial involvement and extensive local tumor cell lysis: a case report.
    Schmiester M; Tranter E; Lorusso A; Blaschke F; Geisel D; Bullinger L; Damm F; Na IK
    BMC Cardiovasc Disord; 2022 Feb; 22(1):31. PubMed ID: 35120455
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical outcomes of AIDS-related Burkitt lymphoma: a multi-institution retrospective survey in Japan.
    Kojima Y; Hagiwara S; Uehira T; Ajisawa A; Kitanaka A; Tanuma J; Okada S; Nagai H
    Jpn J Clin Oncol; 2014 Apr; 44(4):318-23. PubMed ID: 24558129
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HIV-associated Burkitt lymphoma: outcomes from a US-UK collaborative analysis.
    Alderuccio JP; Olszewski AJ; Evens AM; Collins GP; Danilov AV; Bower M; Jagadeesh D; Zhu C; Sperling A; Kim SH; Vaca R; Wei C; Sundaram S; Reddy N; Dalla Pria A; D'Angelo C; Farooq U; Bond DA; Berg S; Churnetski MC; Godara A; Khan N; Choi YK; Kassam S; Yazdy M; Rabinovich E; Post FA; Varma G; Karmali R; Burkart M; Martin P; Ren A; Chauhan A; Diefenbach C; Straker-Edwards A; Klein A; Blum KA; Boughan KM; Mian A; Haverkos BM; Orellana-Noia VM; Kenkre VP; Zayac A; Maliske SM; Epperla N; Caimi P; Smith SE; Kamdar M; Venugopal P; Feldman TA; Rector D; Smith SD; Stadnik A; Portell CA; Lin Y; Naik S; Montoto S; Lossos IS; Cwynarski K
    Blood Adv; 2021 Jul; 5(14):2852-2862. PubMed ID: 34283175
    [TBL] [Abstract][Full Text] [Related]  

  • 16. RD-CODOX-M/IVAC with rituximab and intrathecal liposomal cytarabine in adult Burkitt lymphoma and 'unclassifiable' highly aggressive B-cell lymphoma.
    Corazzelli G; Frigeri F; Russo F; Frairia C; Arcamone M; Esposito G; De Chiara A; Morelli E; Capobianco G; Becchimanzi C; Volzone F; Saggese M; Marcacci G; De Filippi R; Vitolo U; Pinto A
    Br J Haematol; 2012 Jan; 156(2):234-44. PubMed ID: 22098541
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Risk factors and treatment of childhood and adolescent Burkitt lymphoma/leukaemia.
    Miles RR; Arnold S; Cairo MS
    Br J Haematol; 2012 Mar; 156(6):730-43. PubMed ID: 22260323
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Outcomes of HIV-associated Burkitt Lymphoma in Brazil: High treatment toxicity and refractoriness rates - A multicenter cohort study.
    Silva WFD; Garibaldi PMM; Rosa LID; Bellesso M; Clé DV; Delamain MT; Rego EM; Pereira J; Rocha V
    Leuk Res; 2020 Feb; 89():106287. PubMed ID: 31864677
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Burkitt's Lymphoma and B-Cell Lymphoma Unclassifiable With Features Intermediate Between Diffuse Large B-Cell Lymphoma and Burkitt's Lymphoma in Patients With HIV: Outcomes in a South African Public Hospital.
    Sissolak G; Seftel M; Uldrick TS; Esterhuizen TM; Mohamed N; Kotze D
    J Glob Oncol; 2017 Jun; 3(3):218-226. PubMed ID: 28717763
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The treatment of Burkitt lymphoma in adults.
    Crombie J; LaCasce A
    Blood; 2021 Feb; 137(6):743-750. PubMed ID: 33171490
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.